ActoFactor™ Human Long R3 Insulin-Like Growth Factor I
- Specification
- Q & A
- Customer Review
Cat.No.
CSC-CTK0334G
Description
Long R3 Insulin-Like Growth Factor I (IGF-I) is a variant of IGF-I with enhanced stability and biological activity. It promotes cell growth and differentiation and is used in research related to tissue repair and development.
Species
Human
Source
E. coli
GeneID
3479
Accession Number
P05019.1
Synonymous Name
LR3 IGF-I / IGF-1, Long Arg^3 Insulin-like Growth Factor I, LR3 IGF1, IGF-I variant
Molecular Mass
Approximately 9 kDa, a monomeric polypeptide chain.
Size
10ug, 100μg, 500μg, 1000μg, Custom
Purity
>95%
Activity
Fully biologically active when compared to standard. The ED50 for LR3 IGF-I/IGF-1, as measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells, is between 0.3 and 1.5 ng/mL, and IGFBP-3 does not inhibit its activity.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions
Usage
This GMP product can be for research use or further manufacturing use.(NOT FOR HUMAN USE)
Storage
Store lyophilized cytokine at -20°C to -80°C.
Shipping
Dry ice
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no.
If your paper has been published, please click here
to submit the PubMed ID of your paper to get a coupon.
Ask a Question
Write your own review